Author

Georgia Sarquella‐Brugada

Hospital Sant Joan de Déu BarcelonaORCID 0000-0002-6857-8904Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1

Frequent Co-Authors

Antonio de Molina-IrachetaiD· 1 shared Borja Vilaplana‐MartíiD· 1 shared Carolina EpifanoiD· 1 shared Déborah Gómez-Domínguez· 1 shared Ignacío Pérez de CastroiD· 1 shared Iván HernándeziD· 1 shared Miguel Sena‐EstevesiD· 1 shared Sergi CésariD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Antonio de Molina-IrachetaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CRISPR/Cas9-mediated elimination of the LMNA c.745C>G pathogenic mutation enhances survival and cardiac function in LMNA-associated congenital muscular dystrophy

Déborah Gómez-Domínguez, Carolina Epifano, Iván Hernández, Borja Vilaplana‐Martí, Sergi César, Antonio de Molina-Iracheta, Miguel Sena‐Esteves, Georgia Sarquella‐Brugada, Ignacío Pérez de Castro

This study uses CRISPR/Cas9 to target a specific mutation in LMNA-associated congenital muscular dystrophy, improving survival and cardiac function in mice.

bioRxiv · Feb 13, 2025 · PreprintBioengineering